Ratutrelvir
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 15, 2024 (NCT06402136)
Timeline
Indications
Mechanism of action
- Replicase polyprotein 1abINHIBITOR
rep inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07157007 | Phase 2 | Sep 30, 2025 | Traws Pharma, Inc. |
| NCT06402136 | Phase 1 | Apr 15, 2024 | Traws Pharma, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Traws Pharma, Inc. | For profit | 2 | 2 | 2 | 2024 |
1 organizations
Page 1 / 1